Akums Drugs and Pharmaceuticals IPO vs Orient Technologies IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Orient Technologies IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Orient Technologies IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Akums Drugs and Pharmaceuticals IPO	Orient Technologies IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited	Elara Capital (India) Private Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Orient Technologies IPO is up to ₹214.76 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Orient Technologies IPO is ₹206.00 per share.

	Akums Drugs and Pharmaceuticals IPO	Orient Technologies IPO
Face Value	₹2 per share	₹10 per share
Issue Price (Lower)	₹646.00 per share	₹195.00 per share
Issue Price (Upper)	₹679.00 per share	₹206.00 per share
Issue Price (Final)	₹679.00 per share	₹206.00 per share
Discount (Retail)
Discount (Employee)	₹64.00 per share
Market Lot Size	22 shares	72 shares
Fresh Issue Size	1,00,14,727 shares	58,25,243 shares
Fresh Issue Size (Amount)	up to ₹680.00 Cr	up to ₹120.00 Cr
OFS Issue Size	1,73,30,435 shares	46,00,000 shares
OFS Issue Size (Amount)	up to ₹1,176.74 Cr	up to ₹94.76 Cr
Issue Size Total	2,73,45,162 shares	1,04,25,243 shares
Issue Size Total (Amount)	up to ₹1,856.74 Cr	up to ₹214.76 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Orient Technologies IPO opens on Aug 21, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Orient Technologies IPO is Aug 01, 2024, and Aug 23, 2024, respectively.

	Akums Drugs and Pharmaceuticals IPO	Orient Technologies IPO
Anchor Bid Date	Jul 29, 2024	Aug 19, 2024
Issue Open	Jul 30, 2024	Aug 21, 2024
Issue Close	Aug 01, 2024	Aug 23, 2024
Basis Of Allotment (Tentative)	Aug 02, 2024	Aug 26, 2024
Initiation of Refunds (Tentative)	Aug 05, 2024	Aug 27, 2024
Credit of Share (Tentative)	Aug 05, 2024	Aug 27, 2024
Listing date (Tentative)	Aug 06, 2024	Aug 28, 2024
Anchor Lockin End date 1	Sep 01, 2024	Sep 24, 2024
Anchor Lockin End date 2	Oct 31, 2024	Nov 23, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Orient Technologies IPO P/E ratio of 17.8.

Akums Drugs and Pharmaceuticals IPO

Orient Technologies IPO

Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	3,516.37	3,266.53	3,069.05
Revenue	4,212.21	3,700.93	3,694.52
Profit After Tax	0.79	97.82	-250.87
Net Worth	709.50	717.19	621.98
Reserves and Surplus	861.01	868.70	787.79
Total Borrowing	491.56	536.97	357.95
Amount in ₹ Crore

Orient Technologies Limited Financial Information (Restated)

Orient Technologies Limited's revenue increased by 12% and profit after tax (PAT) rose by 8% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	311.14	215.25	176.32	112.45
Revenue	606.86	542.01	469.12	248.96
Profit After Tax	41.45	38.3	33.49	0.13
Net Worth	175.31	128.82	94.11	61.29
Reserves and Surplus	138.79	111.32	76.61	44.79
Total Borrowing	4.82	12.86	2.28	9.22
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

84.94%

97.96%

Promoter Shareholding (Post-Issue)

73.21%

P/E Ratio

17.8

Market Cap

₹857.82 Cr.

ROE

0.11%%

27.26%

ROCE

3.37%%

28.42%

Debt/Equity

0.69

EPS

₹11.57

RoNW

-0.57%

23.64%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Orient Technologies IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 20,85,049 shares in Orient Technologies IPO.

	Akums Drugs and Pharmaceuticals IPO	Orient Technologies IPO
Anchor Investor Reserveration	1,22,05,912 shares	31,27,522 shares
Market Maker Reserveration
QIB	81,37,276 shares	20,85,049 shares
NII	40,68,637 shares	15,63,786 shares
RII	27,12,424 shares	36,48,835 shares
Employee	2,43,902 shares	0 shares
Others
Total	1,51,62,239 shares	72,97,670 shares

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Orient Technologies IPO subscribed 154.84x.

	Akums Drugs and Pharmaceuticals IPO	Orient Technologies IPO
QIB (times)	90.09x	188.79x
NII (times)	42.10x	310.03x
Big NII (times)	47.43x	343.45x
Small NII (times)	31.45x	243.20x
RII (times)	20.80x	68.93x
Employee (times)	4.14x
Other (times)
Total (times)	63.44x	154.84x

Compare with others

Akums Drugs and Pharmaceuticals IPO	Orient Technologies IPO
Interarch Building Products IPO	Baazar Style Retail IPO
Orient Technologies IPO	Bajaj Housing Finance IPO
Unicommerce eSolutions IPO	ECO Mobility IPO
Brainbees Solutions (Firstcry) IPO	Premier Energies IPO
Ceigall India IPO	Interarch Building Products IPO
Sanstar IPO	Unicommerce eSolutions IPO
Bansal Wire IPO	Brainbees Solutions (Firstcry) IPO
Emcure Pharma IPO	Ceigall India IPO
OLA Electric IPO	Akums Drugs and Pharmaceuticals IPO
Vraj Iron and Steel IPO	Sanstar IPO

Comments

Add a public comment...